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Abstract
According to the Centers for Disease Control and Prevention, tuberculosis (TB) is an
infectious disease caused by bacteria and can easily spread in the U.S. and worldwide.
TB infections in the U.S. have been much lower compared to other countries around the
world in the last 40 years, but with the recent increase in an immigrant foreign-born
population, there is a serious risk of the spread of TB. The goal of the study was to look
into U.S.-born vs. foreign-born populations among TB/HIV/homeless cases in the state of
GA from 2014 to 2018. The quantitative study was performed using secondary data from
the CDC Online Tuberculosis Information System. Univariate Chi-square and
multivariate regression analyses were done while using the social ecological model as
theoretical framework. Findings show no evidence of the association between origin of
birth, the odds of being foreign-born TB case in GA and HIV status, rather U.S.-born to
be more HIV positive and homeless. There was no significant association related to sex
and being foreign-born among HIV positive TB cases, and no significant association
related to age groups in homeless TB cases. The study contributes to positive social
change by improving treatment plans to eliminate TB in GA refuting the assumption that
foreign born persons are more likely than U.S.-born persons to be HIV positive and
homeless, thus reducing the stigma among the foreign-born population. These findings
will benefit society and will result in immigrant friendly and less biased society for all.
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Section 1: Foundation of the Study and Literature Review
Tuberculosis Around the World
World Health Organization (WHO, 2020) has reported tuberculosis (TB) as one
of the top 10 causes of death worldwide, with 1.5 million people who died from TB in
2018. The report also focused on 251,000 people who already had HIV and were more
prone to TB infection as a result of their positive HIV status (WHO, 2020). The latest
data from 2018 indicated how serious TB was as there were an estimated 10 million
people who got sick from TB worldwide, including 5.7 million men, 3.2 million women,
and 1.1 million children (WHO, 2020).
TB was first detected in humans in 5800 BCE (Barberis et al., 2017), while in
1882, Koch identified the tuberculin bacteria (Mycobacterium tuberculosis) as the
organism that has caused increased mortality for humans over the centuries. The size of
the bacteria is from 1.3 to 1.5 microns, and it is active at 37C within 3 to 4 weeks.
Additionally, for the development of TB in humans, the required factors are tuberculin
bacteria as the cause of disease, method of entrance in the human body, disease
transmission from person to person, and the immunity of the human organism (Zutic et
al., 2018). Because the most common method of infection (90%) is by airway (Zutic et
al., 2018), TB continues to be the most infectious disease around the world. Despite the
latest medical advances, particularly for people already infected with HIV or people with
low socioeconomic status such as homeless people, TB remains a serious concern.
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Mycobacterium tuberculosis and HIV infections are coendemic and are more susceptible
to the progression of TB (Ayelign et al., 2020).
The WHO (2020) reported that HIV positive individuals are 19 times more likely
to develop active TB. The risk of active TB is greater in individuals suffering from HIV
and malnutritional homelessness, and, as a result, 2.3 million new TB cases in 2018 were
attributable to malnutrition of the homeless globally (WHO, 2020).
The Pan American Health Organization (PAHO, 2020) stated that there were
289,000 estimated incident TB cases in the Americas, with an estimated mortality rate of
22,900, where 26% were a result of TB/HIV coinfection. Focusing on the United States,
TB cases are the lowest compared to other parts of the world, and for that reason, the use
of the Bacille Calmette Guerin vaccine is not recommended (PAHO, 2020).
According to the MMWR report, in 2019, there were 8,920 “provisionally
reported” TB cases in the United States, at a rate of 2.7 per 100,000 persons -- up to 13
million of the estimated number of people in the United States living with a latent TB
infection. The state of Georgia, for example, had an increase in the number of reported
TB cases from 271 cases in 2018 to 301 cases in 2019, according to the Centers for
Disease Control and Prevention MMWR Report (2019).
There was a time when TB was considered a worldwide pandemic (TB Alliance,
2020). When the spread of infectious disease occurs through human populations across a
vast region, for instance, multiple continents and worldwide, it is referred to as a
pandemic (TB Alliance, 2020). Researchers aim to understand how people might respond
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to and cope with the threat of a global pandemic to reduce that threat (Arden & Chilcot,
2020). The Centers for Disease Control and Prevention (CDC) aims to protect Americans
and the international community by providing health promotion, prevention, and
preparedness and to broaden understanding (Mission et al., 2018) during any type of
pandemic; the CDC continues to focus on TB.
Background Information on Immigrants in Georgia
Over the last 25 years, Georgia has become the 11th largest state in the nation,
mostly due to immigration (Census Bureau, 2019). Moreover, there is one particular
region of Georgia with a large immigrant population that has no means for TB prevention
due to lack of funding. TB is a public health problem, especially among immigrants
within the state of Georgia and particularly the immigrant community in the Clarkston
community, where communities many challenges daily from a lack of access to
healthcare, a lack of funding in the community, a prevalence of other diseases that can
coexist with TB, such as HIV, and a lack of economic stability, adequate housing, and
possible risk of homelessness (Guardian, 2017).
In order to understand the immigrant population in Georgia, it is first necessary to
understand the history of Clarkston Community. It was named after the Director of the
Georgia Railroad, Colonel W.W. Clark. According to the City of Clarkston website
(2018), Clarkston owes much of its beginnings to the Georgia Railroad. Beginning in the
1830s, the Georgia Railroad began construction of rail lines that, by 1845, would
eventually connect surrounding Atlanta towns, to include Clarkston, with the merchants
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of Athens to outlets in Augusta and South Carolina. Originally called "New Siding" after
Jake New, a Section Foreman who worked for the Georgia Railroad, the City of
Clarkston was officially chartered by Governor Alexander H. Stevens on December 12,
1882. This community is an immigrant community with 31.8% of population being
foreign born residents who settled close to the railroad to be well connected to other
communities in GA (City of Clarkston, 2018).
General recommendations would be to increase funding for these communities
and to implement cost effective preventive measures for TB among immigrants by
creating small satellite clinics in the area where purified protein derivative (PPD) testing
and other additional medical services could be provided. There are multiple stakeholders
in the area that would be able to help and assist in the process.
The International Rescue Committee (IRC) and the World Relief organizations
are involved with legal immigration to the United States. There is a standard process
when legal immigrants arrive to complete required medical exams (IRC, 2020). One part
of this process is to be tested for TB (PPD test and chest X-ray). Medical records are kept
for each immigrant, the assurance that they do not have TB, and that there is no risk to
others. However, there is opposition toward illegal immigrants where there is lack of this
process in place (IRC, 2020). Public health law and policy plays a major role for many
legislative representatives and their stakeholders with the legal powers at the state level
as essential in TB prevention efforts (Goldberg, 2017). Additional stakeholders who are
associated with this immigrant community are Save the Children Fund, the Global Health
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Institute in collaboration with the universities in Georgia, such as Emory University,
Georgia State University, University of Georgia in Athens, and many other smaller
organizations and agencies.

Table 1
Immigrant TB Program Main Stakeholders’ Analysis
Stakeholder

Interest/Position

Georgia State Supportive but concerned
Legislators

Priority

Strategy

High (high

Educate on pros and cons.

that won’t be popular with

interest and

Demonstrate support by

public. Not convinced that

high power) law enforcement and

pros outweigh cons. Values

communities.

input of law enforcement.
International

Skeptical of value; believes High (high

Convince law enforcement

Rescue

will create more drug use

to be champion. Connect

Committee
(IRC)

interest and

high power) with law enforcement
from jurisdictions with
successful programs.
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World Relief

Sees drug use as problem

Medium

Educate via community

but concerned that program (high

meetings with supportive

will create more drug

interest and

law enforcement present.

use. Values input of law

low power)

enforcement.

Additionally, there is an intersection of public health, public policy, and politics
(Tarantola, 2019). Tarantola (2019) stated,
In an ideal world, evidence of public health gains achievable through new
approaches or technologies should inform public policy, should help shape
political agendas in support of policy change, which should translate into law and
regulations - and then to their application. The goal of this transformative process
should be to yield the highest attainable health benefits to vulnerable individuals
and communities and to society as a whole.
The latest CDC report 2020 indicated high numbers of TB cases among
immigrants who recently arrived in the United States and the importance of preventing
this type of disease from further spreading around the nation. These major findings show
two types of TB infections, pulmonary and extra pulmonary TB (CDC, 2020). Pulmonary
TB was the most common form of post primary disease from 1999 to 2001, and a total of
5,198 cases of TB were recorded among persons who had immigrated to the United
States (CDC, 2020).
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Treatment and Control of Tuberculosis
The WHO (2020) has urged countries around the world to take initiative in terms
of TB control, prevention, and treatment as TB is a curable and preventable infectious
disease, with an estimated 58 million lives saved through TB diagnosis and treatment
between 2000 and 2018. They continue to recommend global TB control, the
implementation to start TB strategy including six main components (WHO, 2020), which
include the following:
•

Using the Directly Observed Therapy Short course (DOTS) procedure

•

addressing TB/HIV, MDR-TB and other challenges

•

strengthening of TB health systems

•

including all healthcare providers

•

making patients and community aware of TB

•

promoting research

DOTS contain five main components, as indicated by WHO (2020):
•

political commitment

•

case detection through quality assurance bacteriology

•

drug supplies

•

surveillance and monitoring systems

•

TB treatment directly observed by monitors

Despite these DOTS strategies in place, multidrug-resistant TB (MDR-TB)
remains to be a public health crisis and a health security threat. According to the WHO
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(2020), there are an estimated 484,000 new cases with resistance to rifampicin, the most
effective first-line drug, of which 78% had MDR-TB. Additional drugs used for TB
treatment as part of DOTS methods are the following: Isoniazid (H), Rifampicin (R),
Pirazinamid (Z), Ethambutol (E), and for 4 months recommended to take only two HRIsoniazid and Rifampicin (WHO, 2020).
Additionally, there were an estimated 10.0 million new cases of TB globally,
including 920,000 new cases in people living with HIV (USAID, 2019). The president’s
Emergency Plan for AIDS Relief is a passage of the legislation launched in 2003 that
placed a heightened priority on U.S. and global TB efforts that continue to this day (U.S.
Congress, 2020). The United States has global TB efforts coordinated under the
international working group of the Federal Tuberculosis Task Force (a coalition of
federal agencies involved in U.S. global and domestic TB efforts; USAID, 2019).
Problem Statement
According to the CDC (2018), TB is an infectious disease caused by bacteria that
can be easily spread from person to person through the air. TB has been a persistent
healthcare problem in many countries around the world for centuries. Most recently, due
to an increased number of immigrants to the United States and drug-resistant TB, there
have been more cases than prior to the beginning of the 21st century (CDC, 2018).
According to Tsang et al. (2020), the United States had 9,272-9,940 cases of TB
reported annually from 2012 to 2016; the incidence rate was 2.9 to 3.2 cases/100,000 of
the population. Most of these cases occurred among the foreign-born population and
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caused the progression of remotely acquired latent TB infection. Tsang et al. stated,
“World Health Organization TB rates are not representative of TB risk among expatriates
in the United States and that TB testing prioritization in the United States might better be
based on U.S. rates by country of birth and years in the United States.”
Marks et al. (2019) reported that HIV will increase TB rates and TB-related health
problems, but there is no difference comparing Black and White race in the United States.
Gomez et al. (2019) studied homelessness and HIV in association with TB while
considering innovative strategies when it comes to TB treatment in order to reduce TB
cases. However, there is a gap in the literature and the need to perform more quantitative
data analysis in order to have a better understanding in preventing future TB rate
increases. Some of the challenges are the difficulties of tracking the development and
surveillance of TB across the state of Georgia.
According to Salindri et al. (2018), who studied TB patients in the state of GA,
targeting the right kind of stakeholders is important. Besides the stakeholders, I
performed quantitative data analysis by looking into secondary data resources such as the
CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) database and
recommended the social policy changes to prevent future TB cases in the state of Georgia
and across the United States.
Recommendation of specific policy changes would be needed for TB and HIV
testing of all patients in the United States, specifically in Georgia, while TB
monitoring/treatment would be done for those who might show a positive PPD skin test.

10
Patients who have HIV and TB with a smear negative test will show higher mortality
while sputum collection and transport, directly observed therapy, monitoring for adverse
events, tracing of people not completing treatment, as well as nutritional support and
health education are needed to avoid mortality (Pathmanathan et al., 2017). In such cases,
there is immunodeficiency present, which can trigger other chronic, infectious diseases
and create a much bigger public health problem.
Over the years, many studies have been conducted on TB alone, but there was one
study done on both TB and HIV in the state of North Carolina. Pearson et al. (2019)
conducted a retrospective, cross-sectional study where about 300 employees were tested
for TB and HIV in North Carolina, of which 22% were immigrants and foreign-born
employees. Out of entire group studied, they were TB positive at 54% while U.S. born
employees tested showed 12% TB positive results. The CDC (2018) reported a
correlation between TB and HIV, and when these two diseases are combined, they can
decrease life longevity. If a patient was untreated for a latent TB infection, the HIV
infection contributed to the development of TB at a higher rate than for a patient who was
not HIV infected.
Homelessness as a socioeconomic status (SES) predictor additionally complicates
the situation and increases TB and HIV rates (CDC, 2018) due to a lack of proper
hygiene and access to healthcare. For these reasons, I based this quantitative study on
HIV and homelessness as an SES predictor, studying how it relates to TB cases in
Georgia.
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Minorities have the greatest burden of having TB, including the foreign-born
population, while homelessness significantly impacts their SES in the United States
(Khan et al., 2018). People who experience homelessness have a higher prevalence of
comorbidities such as HIV infection, mental illness, and substance use disorders that also
increase the risk of progression to TB in the United States (Khan el al., 2018).
Munn et al. (2015) used a homeless shelter in Washington state for the setting of
their study and assessed risk factors for TB infection They determined that birthplace and
the longevity of exposure had a predisposition to TB infection. However, there has been
no research study done for the state of Georgia for the timeframe of 2014 to 2018,
particularly looking into the correlation among TB, HIV, and homelessness. An extensive
literature search did not reveal any published articles or evidence of this type of research
being done for the state of Georgia.
Purpose of the Study
According to Soriano (2020), different ethnic communities should have multiple
partnerships, promote equality, and engage diverse stakeholders where there is mutual
understanding, respect, and established norms when it comes to TB/HIV prevention. The
rationale for doing this type of quantitative research study was to determine the gap
related to TB cases (U.S. born/foreign-born population) in the state of Georgia in relation
to HIV status and homelessness. According to the CDC (2018), the homelessness
condition increases the risk of TB and HIV infection, and there is a gap when it comes to
the level of TB/HIV related to homelessness with the focus on the state of Georgia for the
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last 5 years of quantitative data available. This has never been studied, and for that
reason, the CDC (2018) is collaborating with many national public health organizations
in order to improve screening, diagnosis, and treatment for people who are homeless. The
CDC is also collaborating with local and state healthcare agencies to support homeless
population. In recent years, the number of HIV cases has increased for the state of
Georgia, and my focus was to determine the effect it would have on TB prevalence.
In order to support this rational even further, the correlation between TB and HIV
and TB and homelessness was evaluated and researched for the purpose of having
successful preventive measures and interventions at local and state levels for GA. Marks
et al. (2019) stated that about half a million people immigrate to the United States along
with about 160 million visitors each year, not to mention an unknown number of illegal
immigrants. Because there is no way for illegal immigrants to be tested for TB or HIV
and because they might be homeless for a while, there is no accurate number to report.
Additionally, Marks et al. found that patient mortality due to HIV positive status was
more prevalent in U.S. born population compared to the foreign-born population.
Research Questions and Hypotheses
Research Question (RQ)1: What is the relationship between
the sociodemographic and clinical characteristics of the U.S. born and foreign-born
population (origin of birth) in TB cases for the state of Georgia from 2014 to 2018?
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H10: There is no relationship between the sociodemographic and clinical
characteristics of U.S. born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.
H1A: There is a relationship between the sociodemographic and clinical
characteristics of U.S. born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.
RQ2: What is the relationship between HIV status in TB cases for the state of
Georgia from 2014-2018?
H20: There is no relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018.
H2A: There is a relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018.
RQ3: What is the relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018?
H30: There is no relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018.
H3A: There is a relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018.
My hypothesis was that origin of birth (U.S. born/foreign-born population),
homelessness, and HIV status as independent variables would make a significant impact
in TB cases for the state of Georgia during the time from 2014 to 2018. I believed that
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with the increase in immigration, homelessness, and HIV rates, in recent years 2014 to
2018, TB cases would increase and there would be a significant difference for the state of
Georgia. Further, adding more variables such as sociodemographic factors (age, race, and
immigrant ethnicity/country of origin) and clinical characteristics made the study more
interesting.
According to Munn et al. (2015), public health agencies should be working with
homeless shelters and homeless population to help prevent TB, as these “congregate
settings” can increase TB prevalence.
According to Burkholder et al. (2016), researchers have to rely on big data with
no biases involved, at that time the focus should be on research questions and hypotheses
for that particular study. Every research question has a predictor and an outcome variable
to answer the specific research question. In RQ1, I predicted that with the increase in
immigration, the origin of birth in TB cases in relationship with demographics and
clinical characteristics of GA population would be significant in terms of impact from
2014 to 2018. In RQ2, I predicted that with the increase of HIV in TB cases, there would
be a significant impact for the state of Georgia during 2014 to 2018. In RQ3, I predicted
that with the increase of homelessness in TB cases, there would be a significant impact
for the state of Georgia during 2014 to 2018.
Theoretical Framework
According to Creswell (2017), a researcher’s selection of a theoretical framework
and quantitative research design depends on the goals of the study and the literature
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review. My quantitative research involved a deductive approach in that it was intended to
test theory. The study’s three research questions addressed three independent variables
(origin of birth, HIV, and homelessness) in TB cases.
I applied a socioenvironmental framework to the study. From a
socioenvironmental perspective, health is the product of social, economic, and
environmental determinants. This framework provided incentives and created barriers to
the health of individuals and communities, with the ultimate goal of reducing risks within
the community (see Creswell, 2017).
According to the social ecological model (SEM), individual behavior is shaped on
multiple levels, including the organizational, community, policy, interpersonal, and
intrapersonal levels (Glanz et al., 2015). The rationale for using this specific theory was
that it made it possible to show connections between the variables in a simple way.
Homelessness and HIV are variables directly affecting TB cases in the U.S.
born/foreign-born population, and in order to shape individual behavior, organizations,
communities, and state-level officials need to implement specific policies. In light of my
personal and professional engagement and interest in TB, HIV, and homelessness, a
socioenvironmental framework seemed to be the best option for this research. The
socioenvironmental framework further developed my strategy from the beginning to the
end of the implementation process, which was helpful in tracking and preventing TB in
the state of Georgia.
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Mobilize, assess, plan, implement, track is another framework that can be used to
plan and evaluate public health interventions for immigrants within the state of Georgia
where community engagement matters (Turin, 2020). According to Turin (2020), by
engaging all stakeholders, there is more of a community engagement related effort that
will assess all the needs of the community based on the resources available. It will further
develop strategy from the beginning to the end of the implementation process.
Definition of Terms
DOTS treatment: Otherwise known as directly observed short course therapy is type of
treatment used for TB. Medication used for TB treatment as a part of DOTS methods are
the following: Isoniazid (H), Rifampicin (R), Pirazinamid (Z), and Ethambutol (E).
Georgia legislature representatives: A legislator is someone who can see the need
for a new law or changes in an existing law and for that reason introduces a bill such as
TB prevention among immigrants due to the potential that TB can be spread to other
areas or all across the state of GA.
HIV: A type of virus that weakens a person's immune system by destroying
important cells that fight disease and infection. There is no effective cure for HIV (CDC,
2018).
Homelessness: The defined as the state of having no home (Oxford Dictionary,
2020).
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International Rescue Committee (IRC): The organization responding to the
world’s worst humanitarian crises that helps people by providing daily essential clean
water, shelter, health care, education, and empowerment support (IRC, 2019).
Mortality: The number of dead people within 1 year, represented per 100,000
people.
Multidrug resistant tuberculosis (MDR-TB): No effect on TB symptoms while
subjected to multiple drugs used for TB treatment.
Pandemic: An epidemic of infectious disease that has spread through human
populations across a vast region, for instance, multiple continents or even worldwide
(CDC, 2018.)
Stakeholder: Someone who has a stake in the study and would be influential to
make an impact. Stakeholders can be internal and external depending on their status on
the project or within the organization.
TB surveillance: The organized and systematic collection, data analysis, and
interpretation of TB data in order to determine TB patterns or trends at the same time
when looking into HIV and homelessness in relationship with TB in the state of Georgia,
especially when it comes to vulnerable population such as immigrants (CDC, 2020).
Tuberculosis (TB) prevalence: The total number of infected people.
World Relief: The organization that provides emergency relief and communitybased solutions by assisting refugees and immigrants in the United States (World Relief,
2019).
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Nature of the Study
The nature of the study was quantitative data analysis as I explored key study
variables in TB cases such as origin of birth (U.S. born/foreign-born), HIV, and
homelessness (independent variables) in order to determine the relationship between
dependent and independent variables in the state of Georgia during a specific time from
2014 to 2018. I downloaded and used the latest version of SPSS to analyze TB cases in
relationship with origin of birth /HIV/homelessness status for the state of Georgia taking
into consideration demographics and clinical characteristics of the population. The SPSS
tool was used to obtain the results by summarizing the numerical results with univariate
Chi-square and multivariate logistic regression, including the following interpretation:
measures of central tendency, measures of shape, normal distribution, and measures of
dispersion (see Mishra et al., 2019). For example, measures of central tendency are
appropriate tools for most samples, measures of shape can check for variables’ normal
distribution, measures of dispersion check for variability, and percentage calculated
describes the sample within the population (Mishra et al, 2019).
Descriptive statistics and regressions analyses allowed me to further describe,
assume, and report the relationship of TB cases with origin of birth/HIV/homelessness,
including demographics and clinical characteristics of the population once quantitative
data were analyzed, performing more robust complex statistical analyses. This helped me
understand TB and HIV infectious diseases and how there can be better ways of TB and
HIV prevention in the United States. By using quantitative analysis, I additionally
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pinpointed different factors that impacted the population with TB/HIV status,
TB/homelessness status, and TB/origin of birth and the relationship of all of these
variables.
Literature Search and Justification for the Study
A literature search was performed using online resources such as PubMed,
Google Scholar, and Medline. Key search terms included tuberculosis prevalence,
immigration/origin of birth, U.S. born/foreign-born population, HIV/AIDS, homelessness,
multidrug resistant tuberculosis, TB/HIV coinfection, tuberculosis in the United States,
and tuberculosis in Georgia. This search provided me with the knowledge necessary to
conduct the case study research on the subject of TB, HIV, and homelessness. I
determined early in the search process that there were gaps in the literature on TB
prevention in relation to origin of birth, HIV/AIDS status in relation to TB, and
homelessness for the state of Georgia. Justification for this research was based on lack of
results in terms of analyzing specific database CDC WONDER OTIS database, especially
from 2014 to 2018.
Literature Background
The literature review was exceptionally important to assess any earlier research
on TB and comorbidity related to HIV and homelessness as well as to understand the
development of the disease over the years focusing on the state of Georgia in the United
States.
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Selected articles are described here that are related to the key topics of the
literature review: TB, HIV, and homelessness. I reviewed this literature in an effort to
determine what the differences were between U.S.-born versus foreign-born populations
in the United States in relation to TB, HIV, and homelessness.
Researchers have found that HIV infection is linked to an increased risk of TB as
well as TB-related mortality, especially in immigrants (Marks et al., 2019). Given the
increased number of immigrants to Georgia and the United States and the understanding
that TB can easily spread from person to person by air, TB prevention is an important
goal (WHO, 2020). There are also TB disparities among HIV diagnosed U.S.-born
Blacks and U.S.-born Whites where TB rate ratios were 6 to 7 times higher in U.S.-born
Blacks compared to U.S.-born Whites (Marks et al., 2019). Marks et al. (2019) stated that
Black TB patients had also much greater HIV prevalence compared to Whites.
Khan et al. (2018) further looked into minorities, including foreign-born
populations, as they bear the greatest burden of TB infection. For these groups, Khan et
al. found that homelessness significantly impacts their SES in the United States, which
increases their risk to infectious diseases such as TB.
Nwana et al. (2019) stated that it is critical to focus on homeless populations and
provide the right regimen for TB treatment, especially in cases of INH mono-resistant
TB, the most common drug-resistant type of TB in the United States.
Shrestha et al. (2019) studied different transmission models in the United States.
They suggested that Georgia could implement a local-level and state-level TB
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transmission model like those in place in California, Florida, New York and Texas
(Shrestha et al., 2019).
According to Tsang et al. (2020), rates of TB infection in the United States are 10
times higher among homeless individuals than among those who are not homeless.
Moreover, homeless individuals who become infected with TB are less likely to complete
TB treatment (Tsang et al., 2020). Those who are homeless are also more likely to be
exposed to substance abuse (Tsang et al., 2020). TB outbreaks among homeless people
represent an ongoing problem in the United States generally (CDC, 2018), as well as in
the state of Georgia.
Significance
The results of this quantitative research study provide more information on issues
of TB and HIV and how to prevent an increase in the number of TB/HIV cases in the
United States, particularly in the state of Georgia. Additionally, the results of this study
can help the general public and various stakeholders by informing the development of
much-needed social policy changes for preventing future TB/HIV cases, especially
among homeless people who are struggling, without financial or medical security, to cope
with HIV or TB. Georgia could implement local-level and state-level TB transmission
models like those in place in California, Florida, New York and Texas (Shrestha et al.,
2019). It is critical to focus on homeless populations and provide an effective regimen for
TB treatment to members of this group (Nwana et al., 2019), especially in cases of INH
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mono-resistant TB, which is the most common drug-resistant type of TB in the United
States (Salindri et al., 2018).
This study may contribute to public health by increasing awareness of the gap
between U.S.-born and foreign-born populations in the state of Georgia in relation to TB,
HIV, and homelessness during the 2014 to 2018 period. According to Khan et al. (2018),
the origins of disparities between U.S.-born and foreign-born groups are quite
complicated and include differential exposure to TB, historical discrimination, lack of
access to health care or high-quality care, lifestyles, and cultural practices among
population groups. Quantitative data analysis of the CDC WONDER OTIS (online TB
information system) database can also be helpful in further understanding these gaps and
how to prevent future TB/HIV cases in Georgia and the United States.
This study has implications for positive social change, in that public health
professionals, particularly epidemiologists, may draw from the findings in implementing
preventive measures in order to decrease rates of TB, HIV, and homelessness not only in
Georgia but also throughout the country. Social policy related changes could also be
implemented in hospitals, healthcare centers, prisons, and homeless shelters. With this
research study and focus on vulnerable population, future progress can take place to help
immigrants be healthy, happy, and assimilate easier within the society.
Emerging of Multidrug Resistant Tuberculosis (MDR-TB)
TB has been a serious infectious disease spreading easily through the air from
person to person, having no borders in the United States or around the world. It

23
particularly continues to be a major problem with the resistance to isoniazid and rifampin,
two of the most effective TB drugs when used for TB treatment.
According to the WHO (2020), there were about 480,000 new cases and 210,000
deaths because of MDR or not effective TB treatment in patients. For that reason, there is
a need for new TB medication in order to treat this infectious disease in much more
effective way.
The CDC (2018) stated that “new treatments for multidrug-resistant tuberculosis
are urgently needed.” Active research for new drugs is taking place across the country
and in many research laboratories, and major breakthroughs have taken place with the
discovery of bedaquiline and delamanid (CDC, 2018). Initially, the issue of MDRTB
surfaced as a result of drug misuse, raising some questions about the regulation process
when it comes to TB treatment.
The following was recommended by the CDC (2018) to regulate the use of TB
medication:
•

expand and improve the capacity of “drug susceptibility testing”

•

ban over-the-counter sale of TB medication

•

ensure that only certified providers can prescribe new medication

•

employ trained community health workers in rural communities

•

use mobile technology for better TB detection and monitoring purposes
It is further recommended to strengthen laboratories and better monitor patients

(WHO, 2020). There are national TB programs created to closely monitor patients
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exposed to TB who are being treated using new TB medication to make sure there is no
development of resistance (CDC, 2020). India and Brazil are taking the lead on some of
these programs by engaging private practitioners and by providing incentives for doctors
who deliver adequate TB treatment (CDC, 2020). Additionally, the use of technology and
cell phones can be extremely helpful for improvement of TB and HIV treatments in these
developing countries.
The WHO (2020) reported specific guidelines for what they call programmatic
management of drug-resistant TB. They recommended collaborative TB/HIV activities if
patients are diagnosed with both of these diseases:
•

HIV testing and counselling for all TB patients (pulmonary and extra pulmonary)

•

micro bacterial cultures and other more rapid tests

•

anti-TB therapy to avoid mortality in patients with HIV

•

regular treatment follow-up with a specialized team of medical experts

•

effective infection control and monitoring during the treatment

HIV coinfection along with TB is a major challenge in terms of prevention, diagnosis, as
well as the treatment of MDRTB. The CDC (2020) reported higher mortality rates in
these patients.
The WHO (2020) also reported the latest data on the risk of developing TB,
estimated between 16 and 27 times greater in people living with HIV than among patients
without an HIV infection. For example, in 2015, there were an estimated 10.4 million
cases of TB disease globally, including 1.2 million (11%) among people living with HIV.
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Close to 60% (57%) of TB cases among people living with HIV were not diagnosed or
treated, resulting in 390,000 TB-related deaths among people living with HIV (WHO,
2020).
Table 2
HIV-TB Coinfection Recommendations

The recommendation for using ART therapy during TB treatment is critical for
the duration of treatment when it comes to HIV-TB co-infection, (Nihad et. al.,2016)
states the following “Going forward, the standard must be to start ART during TB
treatment,” he says. “However, in uncommon situations, there may be various reasons
why patients may not be initiated on ART.”
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According to Nahid et. al. (2016), case management process will include patient
education as well as counseling, field and home visits, patient reminders and incentives in
order to complete TB/HIV therapies, as mentioned previously. The use of directly
observed therapy (DOT) will also significantly make TB/HIV treatment successful. In
directly observed therapy (DOT) for example, doctors will observe patients take each
dose of medication during the 6-month course of therapy to ensure compliance with the
use of medication. Further Nihad et. al. (2016) stated that “The evidence synthesized in
the new guidelines on case management strategies offers a better appreciation for the
very real value of patient education and counseling, DOT and other interventions to
improve treatment success, and to reduce the risk of poor adherence and potentially
unfavorable outcomes from treatment.”
Tuberculosis in Migrant Populations
Many countries that had low-incidence of TB around the world, noticed reemergence of TB or emergence of multidrug-resistant TB or even greater increase of TB
in case of HIV co-infections (Prasad, Gupta & Banka, 2018). For numerous reasons, we
need to be concerned about this infectious disease that case very easily spread from
person to person and the medication regimen may not be as effective, as it used to be. It is
interesting that we have seen many migrant populations moving around the world due to
financial hardship, lack of food and water resources, wars, overall due to manmade and
natural disasters, and with the migrant populations coming to low-incidence countries
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such as the US in recent years, we are actively monitoring TB if there are any shifts and
changes taking place across the country.
According to Prasad, Gupta and Banka (2018), systematic review can be
completed by selecting multiple different research studies and these can be further
extracted, tabulated, compared and synthesized through findings on immigration and TB
infection “mutually reinforced and exacerbating stigma.” In migrant populations, it can
easily lead to loss of job, homelessness, not being able to have financial mean to survive
without proper access to healthcare and appropriate TB treatment.
Based on this systematic research, it was determined that it is critical to
understand specific migrant populations around the world, the view they may have
regarding TB and some of the issues they face. Further, it needs to be considered place of
birth, country of origin, migrant status, social, economic even legal when implementing
and evaluating best appropriate TB regimen for migrant populations (Prasad, Gupta &
Banka, 2018). “Management of MDR-TB/RR-TB is complicated, costlier, and
challenging and is a concern for human health worldwide. It must be emphasized that
optimal treatment of MDR-TB/RR-TB alone is not sufficient” (Prasad, Gupta & Banka,
2018).
European Union reports the same issues in many countries related to risk of TB
and new migrant populations having an impact on this type of disease. According to
Greenaway et al. (2018), the effectiveness and cost-effectiveness of screening for active
TB was done among migrants in the European Union through another systematic review
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completed. The results show the following based on the six systematic reviews, one
report and three individual studies: “CXR was highly sensitive (98%) but only
moderately specific (75%) with the yield of detecting active TB with CXR screening
among migrants was 350 per 100,000 population overall but ranged widely by host
country (110-2,340), migrant type (170-1,192), TB incidence in source country (19-336)
and screening setting (220-1,720) and where CXR yield was lower (19.6 vs 336/100,000)
and screening the numbers that were higher (5,076 vs 298) among migrants from source
countries with lower TB incidence (≤ 50 compared with ≥ 350/100,000) according to
Greenaway et al. (2018). It looks like cost-effectiveness was the highest among migrants
originating from high (> 120/100,000) TB incidence countries (Greenaway et al., 2018).
In conclusion, active TB screening programs focusing on the migrants from high
TB incidence countries “have the highest yield and based on the systematic review will
be the most cost-effective with the heterogeneity of the estimates from the studies
identified and the small number of studies addressing both the effectiveness and costeffective of active TB screening in migrants limits the ability to provide precise guidance
on which type of migrants to target, the best timing to screen or the optimal threshold of
TB incidence in countries of origin” (Greenaway et al., 2018).
Table 3
Numbers Needed to Screen to Detect One Case of Active TB (Greenaway et al., 2018)
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TB prevalence in country of

Yield of culture-confirmed active
TB/100,000a

origin/100,000

95% CI

NNS b

10.3–
19.7
50–149

95% CI

3,175–
5,076

31.6

9,709

140–
166.2
150–249

602

514–714

749

631–903

194
111–
133.5

250–349

158
283–
335.9

298
254–353
> 350
393
Note. CI: confidence interval; CXR: chest radiography; NNS: numbers needed to screen; TB: tuberculosis.
a

The yield of active TB detection in pre-arrival CXR screening programs for migrants by TB incidence in

country of origin from Aldrige et al. [25].
b

NNS = 1/mean prevalence of active TB found through CXR screening stratified by TB incidence in the

country of origin.

Similar Research Studies in the United States
There were similar studies researched in many parts of the US looking into TB
prevention among different racial/ethnic groups, treatment approach, TB throughout the
history and in recent years emerging of new multidrug-resistant TB also known as MDRTB. Just like within European Union, in the United States we have seen many different
migrant populations cross the border. Screening of these migrant populations is common
for legal migrants, and they are checked for variety of infectious disease, especially TB
for the well-being of migrants and United States citizens, as well. While health

30
screenings can be common practice for legal immigrants, it is much more challenging to
keep track on illegal immigrants and the success of being able to do healthcare screening
is dependent on what type of resources we have available, as well as where the migrant
populations are coming from according to Tsang et al. (2020). Tsang et al. (2020) further
elaborates that due to most recent focus of the World Health Organization with regard to
their continued elimination strategy, it is important to highlight diagnosing and treating of
latent TB infections especially for migrant populations, and learning even more about
multidrug- resistant TB emerging in recent decade due to increased migration not just in
the United States, but also around the world.
“Due to greater exposure to Mycobacterium tuberculosis infection before
migration, migrants moving to low-incidence settings can experience substantially higher
tuberculosis (TB) rates than the native-born population. This review describes the impact
of migration on TB epidemiology in the United States, and how the TB burden differs
between U.S.-born and non-U.S. born populations. The United States has a long history
of receiving migrants from other parts of the world, and TB among non-U.S. born
individuals now represents the majority of new TB cases. Based on an analysis of TB
cases among individuals from the top 30 countries of origin in terms of non-U.S. born TB
burden between 2003 and 2015, it is described how TB risks vary within the non-U.S.
born population according to age, years since entry, entry year, and country of origin
Menzies et al. (2018).
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Variation along each of these dimensions is associated with more than 10-fold
differences in the risk of developing active TB, and this risk is also positively associated
with TB incidence estimates for the country of origin and the composition of the migrant
pool in the entry year (Menzies et al., 2018). According to Menzies et al. (2018), there
are approximately 87 000 lifetime TB cases are predicted for the non-U.S. born
population resident in the United States in 2015, and 5800 lifetime cases for the
population entering the United States in 2015.
Significance of TB Surveillance
TB surveillance by definition is the organized and systematic collection, data
analysis and interpretation of TB data in order to determine tuberculosis patterns or
trends at the same looking into HIV and homelessness in relationship with TB in the state
of Georgia especially when it comes to vulnerable population such as immigrants (CDC,
2020). Based on the results of surveillance, TB control and prevention guidelines can be
established with the ultimate goal to eliminate the disease. The World Health
Organization (2020) has developed a universal surveillance method that categorizes TB
in the following groups, as new cases, relapse cases, transferred in cases, treatment after
default, and failure cases. On the other hand, the disease is classified into pulmonary TB
smear positive, pulmonary TB smear negative and extra pulmonary TB and there are
number of requirements to have in case of TB disease, such as tuberculosis treatment
card, tuberculosis smear examination form and tuberculosis laboratory register according
to WHO (2020).
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Importance of Cost-Effectiveness Analysis for TB Prevention
Besides quantitative secondary data analysis, cost effectiveness analysis can also
be performed with the goal to advocate for TB prevention in immigrants, homeless and
people with co-infections such as TB/HIV. Cost effectiveness analysis is important to
assist public health in determining the cost of health outcomes and the interventions
(Bhattacharya, 2013). It can further help determine budget for immigrants, homeless and
people with both infectious diseases TB/HIV in making some essential public health
decisions.
Conducting the cost-effectiveness analysis on two interventions when it comes to TB:
•

Healthcare system delay for patient diagnosis when it comes to TB
o Immigrants may or may not have healthcare insurance and due to this cost
of having insurance, there may be a delay in access to healthcare system
and patient diagnosis related to TB.

•

Patient delay for weeks when it comes to diagnosis and TB treatment
o Once they are able to get healthcare insurance and the access of healthcare
system, there might be lack of trust with the providers or the new
healthcare system. For these reasons, we can see patient diagnosis or
treatment of TB delays.

Cost effectiveness ratio is calculated as the ratio of the cost associated over the units
of effectiveness. The cost and benefits can change for TB program depending on how
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many people use the program. There are four basic steps to have for TB program
interventions according to Haines et al. (2013):
1. Cost of TB treatment to be determined
2. Benefits of TB treatment to be calculated
3. Compare alternatives to TB treatment
4. Report and plan action for TB treatment
These interventions of TB treatment would be economically feasible, as there are
number of local clinics and other stakeholders contributing to a good cause by offering
their services.
Best long-term savings of the interventions would be that the sooner the
immigrants are enrolled in healthcare programs and the sooner they start TB treatment,
there are more long-term savings as a result of this intervention. Immediate enrollment
can prevent long term negative effects (Haines et al., 2013). Potential health outcomes
would be less TB prevalence and the risk of spreading the disease basically disease
prevention vs. diseases treatment would save money in a long run. Decision tree
modeling that was recommended by (Haines et al., 2013), is provided in real life context
and as that it would be more effective.
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Section 2: Research Design and Data Collection
This quantitative research study was based on the use of secondary data accessed
from the CDC WONDER OTIS TB database from 2014 to 2018. I used federal
government generated datasets and had enough data points over the years for the state of
Georgia in the United States to evaluate the gap by comparing the U.S.-born vs. foreignborn population while examining HIV, clinical characteristics, and SES predictors such
as homelessness and how it related to TB cases. There were some advantages of using a
secondary dataset, such as easy access from a reliable source where it was possible to
analyze data over a longer period of time to be able to analyze data at a state level. An
additional advantage was that the dataset already contained collected and value coded
data where bias was not present or insignificant. The secondary dataset from 2014 to
2018 became available in November 2019, and there were no articles available using the
most current record via CDC WONDER OTIS dataset.
Quantitative research is critical when it comes to data analysis and the way a
researcher could draw conclusions from these results or the research questions they ask
(Creswell, 2017). According to Creswell (2017), it is necessary to establish validity in
quantitative research as well as look at variables such as independent, dependent, or
confounding.
Population and Study Variables
The population for this study was the U.S.-born/foreign-born population,
particularly focused on the state of Georgia. There were multiple study variables that I
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define and explain in more detail below and how they relate to TB infectious disease as
my primary focus.
Origin of Birth (U.S.-Born vs. Foreign-Born Population) in Association With TB
Historically, going back to 1989, the foreign-born population in the United States
had a higher TB prevalence and cases reported compared to the U.S.-born population
(MMWR,2020). The rate of getting TB is 124 per 100,000 where foreign-born
populations develop TB at a higher rate, especially within 5 years from their first entry to
the United States (MMWR, 2020). MMWR (2020) published a plan in the 1990s to
eliminate TB from the United States, with the priority to implement specific strategies to
prevent TB in the foreign-born population with the higher rates of TB. A further report
showed six foreign countries (Mexico, the Philippines, Vietnam, South Korea, Haiti, and
the People's Republic of China) with a total of 3,000 cases (63%) of all the U.S. foreignborn populations with TB. Most of these TB cases in the United States take place among
foreign-born populations because of no symptoms being present at the time of the
medical exam prior to their entry to the United States. According to MMWR, this
foreign-born population comes from countries previously mentioned where half or even
more of adults are infected and are at high risk of developing TB; however, tuberculin
skin test is the only available method for testing TB.
HIV/AIDS Status in Association With TB
According to the MMWR (2020), world TB data revealed a total of 8,920 TB
cases reported in the United States (incidence = 2.7 cases per 100,000 persons) with a
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1.1% decrease from the 9,021 cases in 2018 and the lowest number of U.S. cases reported
since the start in 1953. The MMWR asserted,
Increased diagnosis and treatment of latent TB infection remains essential for
eliminating TB in the United States where approximately 862,000 reported TB
cases occurred among persons living with human immunodeficiency virus (HIV)
infection. In 2018, 1.8 million persons with HIV began TB preventive treatment
(TPT), 88% increase in treatment initiation from 2017. It was determined that
population with HIV are at much greater risk of getting TB disease, as well as
those with TB/HIV would be at a very high risk of dying.
Additionally, the MMWR reported the occurrence of mortality numbers going
down by improving TB and HIV program collaboration and integration by following the
recommendations below:
•

provide HIV testing to all patients with TB

•

screen all persons with HIV for TB disease and co-infection regularly

•

provide early TB and HIV treatment to all patients with TB and HIV

Every state is unique, and each state should look into their own data and analyze them to
determine what kind of regimen or treatment would be the most effective in the case of
HIV/TB coinfection while increasing both TB and HIV testing. There is still much to
improve when it comes to TB/HIV testing as well as monitoring and evaluation of the
treatment of these two infectious diseases.
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Homelessness in Association With TB
According to MMWR (2020), TB outbreaks likely occur among the homeless,
requiring more sustained and aggressive measures than before. It is also required to report
any confirmed or suspected TB cases in the homeless population via an electronic data
system for easier identification of TB cases (MMWR, 2020). As mentioned previously,
any homeless person who might have TB symptoms should also be tested for HIV as
there might be a greater risk to their health in case of HIV/TB coinfection. With all of
these risks of potential coinfections and being in a homeless situation, the state might
have to establish special kinds of shelters or housing for homeless populations with
HIV/TB coinfection (MMWR, 2020). In case of HIV/TB coinfections, contact tracing
can be done to identify infected individuals, including shelter or a new form of housing
established for the homeless; the tuberculin skin test should be administered to staff too.
People with positive tuberculin skin test results should be considered for preventive
therapy according to the guidelines reported in MMWR and follow the specific
recommendations as listed below:
•

“The highest priority should be given to a) detection, evaluation, and reporting of
homeless population who have current symptoms of active TB and b) completion
of an appropriate course of treatment by those diagnosed with active TB.”

•

“The second priority should be screening and preventive therapy for homeless
population who have, or are suspected of having, human immunodeficiency virus
(HIV) infection.”
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•

“The third priority should be the examination and appropriate treatment of
population with recent TB that has been inadequately treated.”

•

“The fourth priority should be screening and appropriate treatment of population
exposed to an infectious (sputum-positive) case of TB. Because contacts are
difficult to define in a shelter population, it is usually necessary to screen all
residents of a shelter when an infectious case is identified.”

•

“The fifth priority should be screening and preventive therapy for homeless
population with known medical conditions that increase the risk of TB, e.g.,
diabetes mellitus.”
Sampling and Source of Information
In this study, there were no human subjects involved as indicated previously only

secondary data was used. The review by Walden University Institutional Review Board
(IRB) was done in September 2020. IRB documentation was submitted to IRB
committee. Since IRB approval did take place, I was able to determine target population
size and there were no ethical concerns with the study prior to the IRB approval.
Sampling strategy was to look into target population as this data was already value coded
and for that reason there was no need to do sampling procedure. All three research
questions were based on the population within the state of Georgia in the United States.
Just to highlight the procedure for data collection, there was no data analyzed until the
official IRB approval was in place.
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Access to this secondary dataset through CDC WONDER OTIS database was
public and open to anyone with internet connection. Simple access to quantitative data
and retrieved through Google or any other search engine, relevant documentation was
included on the website while the source of data is reputable, anonymous and confidential
while it required appropriate essential variables for this study to be selected in the system.
Data Analysis Plan
Quantitative data analysis plan was to use SPSS statistical tool version 25 for data
analysis that stands for Statistical Package for Social Sciences. Further for this statistical
data analysis descriptive statistics, univariate Chi-square and multivariate logistic
regression analyses were used in order to analyze and compare independent variables;
origin of birth, HIV and homelessness in relation to TB cases in the state of Georgia
considering sociodemographic and clinical characteristics of the population. There was
Chi-square statistical data analysis performed for the purpose of testing my hypotheses
due to having categorical variables within this type of dataset, but in order to make this
study more robust had to do multivariate regression analysis as the most critical way to
evaluate these relationships among different variables. Univariable regression was used
as a screening method for deciding which variables to include in multivariable regression
analysis.
Research Question (RQ)1: What is the relationship between
the sociodemographic and clinical characteristics of the U.S. born and foreign-born
population (origin of birth) in TB cases for the state of Georgia from 2014 to 2018?
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H10: There is no relationship between the sociodemographic and clinical
characteristics of U.S. born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.
H1A: There is a relationship between the sociodemographic and clinical
characteristics of U.S. born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.
RQ2: What is the relationship between HIV status in TB cases for the state of
Georgia from 2014-2018?
H20: There is no relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018.
H2A: There is a relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018.
RQ3: What is the relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018?
H30: There is no relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018.
H3A: There is a relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018.
Quantitative secondary dataset with selected variables from the CDC WONDER
OTIS database were extracted and exported to Microsoft Office Excel spreadsheet where
data cleaning and screening procedures were performed as necessary. In terms of threats
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to internal and external validity, they were minimal due to using reliable secondary
dataset from reputable federal agency such as the Centers for Disease Control and
Prevention where strict protocols and procedures were in place related to anonymity,
confidentiality of data collection, and system security of the servers.
Limitations, Challenges, and/or Barriers
At this point in research, it was quite clear of what other barriers would be
evident. Since CDC WONDER OTIS database had publicly available secondary
quantitative data generated by federal government, there was no partner site agreement or
any type of agreement to sign or request. It was easier that way to request, download the
dataset and work on exporting necessary data into SPSS for the purpose of quantitative
data analysis. Technical issues took place at that time while transporting large dataset and
moving it from one system to the next. It was challenging selecting appropriate statistical
methods for these three research questions, but Walden University resources were
available and used in the process.
Electronic reporting system was a good way to achieve rapid, centralized, and
flexible internet-based reporting of data. There were also number of issues with this type
of surveillance, for example; restricted budget for expenses associated with the
maintenance, update of the electronic system, and lack of protection of sensitive
information from hackers. It was critical to protect patient privacy or the integrity of
these secondary data systems in place through the Centers for Disease Control and
Prevention. There was always concern about secondary data use regarding source of data,
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data collection process, data reliability and validity. Yet, there was no perfect
surveillance system in place during this study and every type of surveillance system was
unique in its own way whether we were looking into different datasets across the country,
different states or different countries around the world.
Summary
Just to summarize as previously mentioned, this was quantitative research study
using reliable and reputable secondary data from CDC WONDER OTIS database that
was publicly available. The data was analyzed using SPSS statistical tool version 25
provided by Walden University where univariate Chi-Square and multivariate logistic
regression testing was performed in order to test my hypotheses. Secondary data was
collected from 2014 to 2018 in this database, and it was the most current available data
from the website that was anonymous, confidential without any type of identifiers.
Further, the results of quantitative data analysis were discussed in Section 3.
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Section 3: Presentation of the Results and Findings
To present the results and findings, secondary quantitative data were retrieved and
imported into an Excel spreadsheet with all TB cases of U.S.-born and foreign-born
populations for the state of Georgia in the United States from 2014 to 2018. TB cases
were recorded by the GA Department of Public Health and shared within the CDC OTIS
WONDER database system. Data were grouped by gender, age, race, country of birth,
homelessness, clinical characteristics, and HIV status in an Excel spreadsheet and were
then imported from an Excel spreadsheet into SPSS Version 25, where I completed
statistical analysis such as descriptive data analysis, univariate Chi-square, and
multivariate logistic regression testing.
Due to the CDC’s reliable source of the secondary data collection, there was no
concern of any particular threats to validity or reliability of this type of data being used
and analyzed as part of my study. There were no personally identifiable patient
information characteristics, and all the IRB requirements were followed in the process,
with prior official IRB approval in September 2020.
My main focus was to study three independent variables: origin of birth, HIV, and
homelessness and their relationship in all TB cases for the state of Georgia 2014 to 2018,
focusing on sociodemographic and clinical characteristics of this population. In my
secondary dataset, N equaled 1,518 patients who were positive for TB from 2014 to 2018
in the state of Georgia. Specific categorical variables were coded in SPSS, as appropriate.
For example, origin of birth had two categories: U.S.-born and foreign-born. U.S. born
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was coded as 1 and foreign-born was coded as 2, with all patients having positive TB
status.
My proposal was officially approved in August 2020, and IRB approval was
received early September 2020. At that time, I retrieved secondary quantitative data and
used descriptive analysis, univariate Chi-Square, and multivariate logistic regression
testing to analyze the data of U.S.-born and foreign-born TB cases in relationship with
three independent variables, HIV and homelessness, sociodemographic, and clinical
characteristics of the GA population. In the process of quantitative data analysis, the
independent variables had a confidence level of 95% where statistics on all three
variables were reported, and there was a positive correlation between these variables. It
was important to support either the null or alternative hypothesis by performing statistical
analysis such as univariate Chi-square and multivariate regression analyses.
Description of Study Population in Georgia
Table 4
Patients With TB in Georgia 2014-2018 and the Magnitude of the TB Incidence (New
Case) Rates in Georgia From 2014-2018

Rate per
Year
2018

Cases
271

Percent of total
17.85%

100,000
2.58

45
2017

293

19.30%

2.81

2016

302

19.89%

2.93

2015

318

20.95%

3.12

2014

334

22.00%

3.32

Total

1,518

100.00%

2.95

Note. The Georgia TB Case Count: 1,518
a. TB incidence rate per 100,000, for the period studied: 2.95
b. The tuberculosis average annual incidence in Georgia per 100,000 person-years
c. The rate among US-born persons per 100,000 and the rate among non-US-born
persons per 100,000
[Rates are only available for national or state data when variables with population
data are picked. Variables that support rates are Year, Age Group, Sex, Bridged
Race / Ethnicity and State.]
Quantitative Data Analysis Results
RQ1: What is the relationship between the sociodemographic and clinical
characteristics of US-born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018?
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Table 5
Univariate Relationship Between Sociodemographic and Clinical Characteristics and TB
Incidence Rates of U.S.-Born Persons and Non-U.S. Born Persons in Georgia

Gender
Male
Female
Age at diagnosis,
<20
20-29
30-39
40-49
50+
Race/ethnicity
Asian or Pacific
Islander, Non-Hispanic
Black or African
American, NonHispanic
Hispanic or Latino
White, NonHispanic
Unknown
Country of birth
United States
Other
Mexico
Vietnam
Philippines
Somalia
Laos
Injection drug user
No
Not Reported
Yes

U.S.-born
(n = 780)

Non-U.S. born
(n = 737)

535 (54.3)
245 (46.1)

451 (45.7)
286 (53.9)

0.0029

102 (71.8)
72 (36.7)
105 (36.6)
106 (45.5)
395 (59.9)

40 (28.2)
124 (63.3)
182 (63.4)
127 (54.5)
264 (40.1)

<.0001

25 (6.8)

341 (93.2)

<.0001

543 (75.8)
47 (19.4)

173 (24.2)
195 (80.6)

162 (87.1)
3 (42.9)

24 (12.9)
4 (57.1)

780 (100)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
507 (100)
119 (100)
76 (100)
19 (100)
12 (100)
4 (100)

<.0001

750 (51.4)
16 (36.4)
14 (100)

709 (48.6)
28 (63.6)
0 (0)

0.0003

p-value
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Non-injection drug user
No
Not reported
Yes
Excessive alcohol use
No
Not reported
Yes
Homeless
No
Yes
Unknown
HIV status
Negative
Positive
Not reported
Correctional facility
resident
No
Yes
Unknown
Previous TB diagnosis
No
Yes
Unknown
Verification criteria
Clinical case
Definition
Positive culture
Positive nucleic
Acid amplification test
Provider diagnosis
Unknown
Site of disease
Both
Extrapulmonary
Pulmonary
Unknown
Multidrug-resistant
No

643 (48)
16 (39)
121 (88.3)

696 (52)
25 (61)
16 (11.7)

<.0001

613 (47.7)
19 (39.6)
148 (80.9)

673 (52.3)
29 (60.4)
35 (19.1)

<.0001

658 (48.1)
120 (82.8)
2 (66.7)

711 (51.9)
25 (17.2)
1 (33.3)

<.0001

642 (49.6)
84 (63.2)
54 (59.3)

651 (50.4)
49 (36.8)
37 (40.7)

0.0015

753 (51.2)
23 (54.8)
4 (80)

717 (48.8)
19 (45.2)
1 (20)

0.6511

748 (52.1)
30 (39.5)
2 (40)

688 (47.9)
46 (60.5)
3 (60)

0.032

125 (44.8)
566 (51.8)

154 (55.2)
526 (48.2)

0.0019

14 (42.4)
71 (65.7)
4 (80)

19 (57.6)
37 (34.3)
1 (20)

72 (51.8)
114 (40.6)
592 (54.2)
2 (50)

67 (48.2)
167 (59.4)
501 (45.8)
2 (50)

0.0003

553 (51.8)

515 (48.2)

0.8814
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Not applicable
Not reported
Yes
Directly observed
therapy
Both
Direct only
Not applicable
Not reported
Self only
Tested for isoniazid
susceptibility
No
Not applicable
Yes
Tested for isoniazid &
rifampin susceptibility
No
Not applicable
Yes
Completion of therapy
within 1 year
No
Not applicable
Not reported
Yes
Vital status
Alive
Dead
Not reported

211 (51)
11 (47.8)
5 (41.7)

203 (49)
12 (52.2)
7 (58.3)

51 (45.5)
569 (53.3)
152 (49.4)
8 (42.1)
0 (0)

61 (54.5)
498 (46.7)
156 (50.6)
11 (57.9)
11 (100)

0.0019

11 (47.8)
211 (51)
558 (51.7)

12 (52.2)
203 (49)
522 (48.3)

0.9142

11 (47.8)
211 (51)
558 (51.7)

12 (52.2)
203 (49)
522 (48.3)

0.9142

41 (53.9)
238 (49.5)
18 (47.4)
483 (52.4)

35 (46.1)
243 (50.5)
20 (52.6)
439 (47.6)

0.6793

748 (50.8)
23 (82.1)
9 (50)

723 (49.2)
5 (17.9)
9 (50)

0.0045

Table 6
Univariate Logistic Regression for Odds of Being a Foreign-Born TB Case in Georgia
Between 2014 and 2018 and Sociodemographic and Clinical Characteristics
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Sex

M
F

933
489

Odds Ratio
(95% CI)
0.66 (0.53-0.82)
-

Race

Asian or AIAN
Black or African
American
White

357
687

13.02 (8.21-20.64)
0.31 (0.24-0.41)

<.001
<.001

378

-

.

Age groups

20-29
30-39
40-49
50+
<20

190
272
229
611
120

3.23 (2.00-5.21)
3.11 (1.99-4.88)
2.32 (1.46-3.66)
1.30 (0.86-1.96)
-

<.001
<.001
<.001
0.212
.

<.001

Homeless

Yes
No

141
1281

0.18 (0.12-0.29)
-

<.001
.

<.001

HIV status

Positive
Negative

132
1290

0.56 (0.39-0.81)
-

0.002
.

0.002

Diagnosis
year

2015
2016
2017
2018
2014

297
285
280
250
310

1.07 (0.78-1.47)
1.08 (0.78-1.49)
1.34 (0.97-1.86)
1.41 (1.01-1.97)
-

0.683
0.645
0.074
0.045
.

0.172

1422

0.99 (0.99-1.00)

0.036

0.036

Covariate

Level

AGE

N

OR Pvalue
<.001
.

Type3 Pvalue
<.001

<.001

Table 7
Multivariable logistic regression for odds of being a foreign-born TB case in Georgia
between 2014 to 2018 and sociodemographic and clinical characteristics

Covariate
Sex

Race

Level
M
F
Asian or AIAN

Odds Ratio (95% CI)
0.69 (0.52-0.91)
-

OR P-value
0.009
-

Type3 P-value
0.009

15.47 (9.58-24.97)

<.001

<.001
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Covariate

Level
Black or African
American
White

Odds Ratio (95% CI)
0.30 (0.22-0.40)

OR P-value
<.001

-

-

Type3 P-value

Age groups

20-29
30-39
40-49
50+
<20

5.18 (2.81-9.56)
6.03 (3.38-10.77)
4.49 (2.47-8.18)
1.76 (1.03-3.03)
-

<.001
<.001
<.001
0.040
-

<.001

Homeless

Yes
No

0.34 (0.19-0.58)
-

<.001
-

<.001

HIV status

Positive
Negative

1.05 (0.67-1.64)
-

0.836
-

0.836

2015
2016
2017
2018
2014
* Number of observations used = 1422.

0.90 (0.60-1.37)
1.04 (0.68-1.57)
1.46 (0.96-2.21)
1.09 (0.71-1.67)
-

0.634
0.861
0.074
0.684
-

0.216

Diagnosis
year

Population with N=1518 had 771 U.S.-born and 747 foreign-born frequencies
according to Table 5. Significance level is presented in Tables 6 and 7. When we have
significance number less than 0.05 that means origin of birth variable from the research
question #1 will predict and impact the other variable while supporting the alternative
hypothesis “There is a relationship between the sociodemographic and clinical
characteristics and U.S.-born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.”
According to multivariate logistic regression analysis for RQ #1, the association
between U.S.-born and foreign-born population (origin of birth) or the odds of being
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foreign-born TB case in Georgia and HIV status was not retained (Table 7) and diagnosis
year. While adjusting for other variables sex, age, race and homeless with the p-value
<0.005 where there was significance. Missing cases were not included in the analysis.
Additionally, TB cases were presented by each year from 2014-2018 in Table 4.
RQ2: What is the relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018?
Table 8
Relationship between HIV status in TB cases for the state of Georgia from 2014 to 2018
and sociodemographic and clinical characteristics

HIV

HIV

HIV
P-

Negative

Positive

Unknown
value

(n=1,293)

(n=133)

(n=92)

Gender
0.076
Men

843 (85.4)

93 (9.4)

51 (5.2)

Women

450 (84.7)

40 (7.5)

41 (7.7)

5

Age at diagnosis,
<.000
<20

119 (83.8)

1 (0.7)

22 (15.5)

1

52
30-39

241 (83.7)

33 (11.5)

14 (4.9)

40-49

190 (81.5)

39 (16.7)

4 (1.7)

20-29

178 (90.8)

12 (6.1)

6 (3.1)

50+

565 (85.7)

48 (7.3)

46 (7)

Race/ethnicity
<.000
Asian or Pacific Islander

337 (91.8)

10 (2.7)

20 (5.4)

Black or African American

584 (81.6) 102 (14.2)

30 (4.2)

Hispanic or Latino

207 (85.5)

12 (5)

23 (9.5)

White, Non-Hispanic

161 (86.6)

7 (3.8)

18 (9.7)

4 (57.1)

2 (28.6)

1 (14.3)

Unknown

1

Country of birth
0.148
United States

634 (82.2)

84 (10.9)

53 (6.9)

Other

445 (86.9)

39 (7.6)

28 (5.5)

Mexico

108 (88.5)

6 (4.9)

8 (6.6)

Vietnam

72 (92.3)

4 (5.1)

2 (2.6)

Philippines

18 (94.7)

0 (0)

1 (5.3)

Somalia

12 (100)

0 (0)

0 (0)

4 (100)

0 (0)

0 (0)

Laos

5

53
Foreign Born
0.001
US born

642 (82.3)

84 (10.8)

54 (6.9)

Non-US born

651 (88.3)

49 (6.6)

37 (5)

5

Injection drug user
<.000
No

1255 (86)

121 (8.3)

83 (5.7)

Not Reported

30 (66.7)

6 (13.3)

9 (20)

8 (57.1)

6 (42.9)

0 (0)

Yes

1

Non-injection drug user
1159

<.000

No

(86.6)

98 (7.3)

82 (6.1)

Yes

105 (78.4)

29 (21.6)

0 (0)

29 (64.4)

6 (13.3)

10 (22.2)

Not Reported

1

Excessive alcohol use
1096

0.000

No

(85.2)

109 (8.5)

81 (6.3)

Yes

160 (89.4)

19 (10.6)

0 (0)

37 (69.8)

5 (9.4)

11 (20.8)

Not Reported
Homeless

9
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<.000
No

1178 (86)

104 (7.6)

87 (6.4)

Yes

112 (79.4)

29 (20.6)

0 (0)

3 (37.5)

0 (0)

5 (62.5)

Unknown

1

Correctional facility resident
0.045
Yes

36 (100)

0 (0)

0 (0)

6

1254
No

(85.3)

129 (8.8)

87 (5.9)

Unknown

3 (25)

4 (33.3)

5 (41.7)

Previous TB diagnosis
0.087
Yes

67 (90.5)

7 (9.5)

0 (0)

(85.1)

125 (8.7)

89 (6.2)

3 (42.9)

1 (14.3)

3 (42.9)

5

1223
No
Unknown
Verification Criteria
<.000
Clinical Case Definition

247 (88.5)

10 (3.6)

22 (7.9)

Positive Culture

933 (85.4)

100 (9.1)

60 (5.5)

1
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Positive Nucleic Acid
Amplification Test
Positive Smear
Provider Diagnosis
Unknown

29 (100)

0 (0)

0 (0)

5 (100)

0 (0)

0 (0)

79 (73.1)

20 (18.5)

9 (8.3)

0 (0)

3 (75)

1 (25)

Site of disease
<.000
Both

104 (74.8)

28 (20.1)

7 (5)

Extrapulmonary

233 (82.6)

22 (7.8)

27 (9.6)

Pulmonary

952 (87.1)

83 (7.6)

58 (5.3)

4 (100)

0 (0)

0 (0)

Unknown

1

Multidrug-Resistant
0.182
No

910 (85.1)

99 (9.3)

60 (5.6)

Yes

11 (100)

0 (0)

0 (0)

350 (84.1)

34 (8.2)

32 (7.7)

22 (100)

0 (0)

0 (0)

Not Applicable
Not Reported

6

Directly Observed Therapy
0.000
Both

100 (89.3)

7 (6.3)

5 (4.5)

4

56
Direct Only

919 (86.1)

102 (9.6)

46 (4.3)

Not Applicable

254 (82.2)

20 (6.5)

35 (11.3)

10 (50)

4 (20)

6 (30)

10 (100)

0 (0)

0 (0)

Not Reported
Self Only
Tested for Isoniazid Susceptibility

0.134
No

22 (100)

0 (0)

0 (0)

Yes

921 (85.2)

100 (9.3)

60 (5.6)

Not Applicable

350 (84.3)

33 (8)

32 (7.7)

7

Tested for Isoniazid & Rifampin
Susceptibility
0.134
No

22 (100)

0 (0)

0 (0)

Yes

921 (85.2)

100 (9.3)

60 (5.6)

Not Applicable

350 (84.3)

33 (8)

32 (7.7)

7

Completion of Therapy Within One
Year
<.000
No

57 (75)

13 (17.1)

6 (7.9)

Yes

810 (87.9)

78 (8.5)

34 (3.7)

1

57
Not Applicable

393 (81.5)

40 (8.3)

49 (10.2)

Not Reported

33 (86.8)

2 (5.3)

3 (7.9)

Vital Status
1272

<.000

Alive

(86.4)

128 (8.7)

72 (4.9)

Dead

11 (45.8)

0 (0)

13 (54.2)

Not Reported

10 (45.5)

5 (22.7)

7 (31.8)

1

Table 9
Univariable Logistic regression for odds of being a HIV positive TB case in the state of
Georgia from 2014 to 2018 and sociodemographic and clinical characteristics

N
933
489

Odds Ratio (95%
CI)
1.23 (0.83-1.81)
-

OR Pvalue
0.300
.

Type3 Pvalue
0.300

Asian or AIAN
Black or African
American
White

357
687

0.54 (0.25-1.19)
3.33 (2.01-5.53)

0.127
<.001

<.001

378

-

.

20-29
30-39

190
272

0.047
0.007

40-49

229

50+
<20

611
120

8.02 (1.03-62.50)
15.86 (2.14117.49)
24.42 (3.31180.10)
10.14 (1.39-74.21)
-

Foreign Born Yes

699

0.56 (0.39-0.81)

0.002

Covariate
Sex

Race

Age groups

Level
M
F

<.001

0.002
0.022
.
0.002
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No

N
723

Odds Ratio (95%
CI)
-

Homeless

Yes
No

141
1281

2.96 (1.88-4.67)
-

<.001
.

<.001

Diagnosis
year

2015
2016
2017
2018
2014

297
285
280
250
310

0.76 (0.45-1.29)
0.90 (0.54-1.50)
0.68 (0.39-1.18)
0.52 (0.28-0.96)
-

0.310
0.673
0.171
0.037
.

0.258

1422

1.00 (0.99-1.01)

0.924

0.924

Covariate

Level

AGE

OR Pvalue
.

Type3 Pvalue

Table 10
Multivariable Logistic regression for odds of being a HIV positive TB case in the state of
Georgia from 2014 to 2018 and sociodemographic and clinical characteristics

Sex

M
F

Odds Ratio (95%
CI)
1.09 (0.71-1.65)
-

Race

Asian or AIAN
Black or African American
White

0.55 (0.25-1.24)
3.34 (1.95-5.72)
-

0.151
<.001
-

<.001

Age groups

20-29
30-39

8.42 (1.07-66.24)
15.87 (2.12118.57)
23.21 (3.12172.76)
9.15 (1.24-67.54)
-

0.043
0.007

<.001

Covariate

Level

40-49
50+
<20

OR P-value

Type3 P-value

0.702
-

0.702

0.002
0.030
-
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Homeless

Yes
No

Odds Ratio (95%
CI)
1.94 (1.16-3.25)
-

Foreign Born

Yes
No

1.15 (0.72-1.82)
-

0.556
-

0.556

0.81 (0.46-1.41)
0.98 (0.57-1.70)
0.76 (0.42-1.37)
0.67 (0.35-1.28)
-

0.454
0.955
0.365
0.228
-

0.687

Covariate

Level

Diagnosis year 2015
2016
2017
2018
2014
* Number of observations used = 1422.

OR P-value

Type3 P-value

0.012
-

0.012

Population with N=1518 with 1293 negative and 133 positive HIV cases, 48 not offered,
25 refused to report and 19 unknowns. These numbers were reported in Table 8. According
to multivariate logistic regression analysis for RQ #2, there was no significant association
related to sex, foreign-born and diagnosis year for adds of being a HIV positive TB case in
Georgia from 2014 to 2018. While adjusting for other variables such as age, race and
homelessness with the p-value <0.005 where there was significance (Table 10). Missing
cases were not included in the analysis.
RQ3: What is the relationship between homelessness in TB cases for the state of Georgia
from 2014 to 2018?
Table 11
Relationship between homelessness in TB cases for the state of Georgia from 2014 to
2018 and sociodemographic and clinical characteristics

60
Homeless No

Homeless Yes
P-value

(n=1,369)

(n=145)

855 (86.9)

129 (13.1)

514 (97)

16 (3)

<20

135 (95.1)

7 (4.9)

20-29

183 (93.4)

13 (6.6)

30-39

269 (94.1)

17 (5.9)

40-49

204 (87.6)

29 (12.4)

578 (88)

79 (12)

359 (98.1)

7 (1.9)

604 (84.6)

110 (15.4)

Hispanic or Latino

230 (95.4)

11 (4.6)

White, Non-Hispanic

170 (91.4)

16 (8.6)

6 (85.7)

1 (14.3)

Gender
Men
Women

<.0001

Age at diagnosis,

50+

0.0096

Race/ethnicity
Asian or Pacific Islander, NonHispanic
Black or African American, NonHispanic

Unknown
Country of birth

<.0001
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United States

651 (84.7)

118 (15.3)

Other

496 (97.3)

14 (2.7)

Mexico

115 (94.3)

7 (5.7)

Vietnam

73 (93.6)

5 (6.4)

Philippines

19 (100)

0 (0)

Somalia

12 (100)

0 (0)

3 (75)

1 (25)

US born

658 (84.6)

120 (15.4)

Non-US born

711 (96.6)

25 (3.4)

Negative

1178 (91.3)

112 (8.7)

Positive

104 (78.2)

29 (21.8)

87 (95.6)

4 (4.4)

1326 (90.9)

133 (9.1)

Not Reported

29 (74.4)

10 (25.6)

Yes

14 (87.5)

2 (12.5)

1247 (93.2)

91 (6.8)

Laos

<.0001

Foreign Born
<.0001

HIV status

Not reported

<.0001

Injection drug user
No

0.0011

Non-injection drug user
No

<.0001
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Not Reported

29 (74.4)

10 (25.6)

Yes

93 (67.9)

44 (32.1)

1188 (92.5)

97 (7.5)

37 (80.4)

9 (19.6)

144 (78.7)

39 (21.3)

No

1339 (91.2)

130 (8.8)

Yes

29 (70.7)

12 (29.3)

1 (25)

3 (75)

No

1299 (90.6)

134 (9.4)

Yes

66 (86.8)

10 (13.2)

4 (80)

1 (20)

Clinical Case Definition

260 (93.9)

17 (6.1)

Positive Culture

980 (89.8)

111 (10.2)

29 (100)

0 (0)

96 (88.9)

12 (11.1)

Excessive alcohol use
No
Not Reported
Yes

<.0001

Correctional facility resident

Unknown

<.0001

Previous TB diagnosis

Unknown

0.271

Verification Criteria

Positive Nucleic Acid Amplification
Test
Provider Diagnosis

0.0535
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Unknown

4 (44.4)

5 (55.6)

Both

126 (90.6)

13 (9.4)

Extrapulmonary

272 (97.5)

7 (2.5)

Pulmonary

967 (88.6)

125 (11.4)

4 (100)

0 (0)

No

955 (89.6)

111 (10.4)

Not Applicable

379 (91.8)

34 (8.2)

Not Reported

23 (100)

0 (0)

Yes

12 (100)

0 (0)

Both

105 (93.8)

7 (6.3)

Direct Only

948 (88.8)

119 (11.2)

Not Applicable

288 (94.4)

17 (5.6)

Not Reported

15 (88.2)

2 (11.8)

Self Only

13 (100)

0 (0)

23 (100)

0 (0)

379 (91.8)

34 (8.2)

Site of disease

Unknown

<.0001

Multidrug-Resistant
0.143

Directly Observed Therapy
0.0102

Tested for Isoniazid Susceptibility
No
Not Applicable

0.1392
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Yes

967 (89.7)

111 (10.3)

23 (100)

0 (0)

Not Applicable

379 (91.8)

34 (8.2)

Yes

967 (89.7)

111 (10.3)

66 (86.8)

10 (13.2)

Not Applicable

448 (93.7)

30 (6.3)

Not Reported

31 (81.6)

7 (18.4)

824 (89.4)

98 (10.6)

Alive

1329 (90.5)

140 (9.5)

Dead

24 (100)

0 (0)

Not Reported

16 (76.2)

5 (23.8)

Tested for Isoniazid & Rifampin
Susceptibility
No

0.1392

Completion of Therapy Within One Year
No

Yes

0.0083

Vital Status

Table 12
Univariable Logistic regression for odds of being a Homeless TB case in the state of
Georgia from 2014 to 2018 and sociodemographic and clinical characteristics

0.1223
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Sex

M
F

933
489

Odds Ratio (95%
CI)
4.93 (2.85-8.53)
-

Race

Asian or AIAN
Black or African
American
White

357
687

0.38 (0.17-0.83)
2.75 (1.73-4.37)

0.015
<.001

378

-

.

Age groups

20-29
30-39
40-49
50+
<20

190
272
229
611
120

1.69 (0.59-4.86)
1.44 (0.51-4.02)
3.20 (1.20-8.52)
3.41 (1.35-8.62)
-

0.332
0.490
0.020
0.009
.

0.001

Foreign Born

Yes
No

699
723

0.18 (0.12-0.29)
-

<.001
.

<.001

HIV status

Positive
Negative

132
1290

2.96 (1.88-4.67)
-

<.001
.

<.001

Diagnosis year

2015
2016
2017
2018
2014

297
285
280
250
310

0.42 (0.26-0.67)
0.35 (0.21-0.58)
0.23 (0.13-0.41)
0.22 (0.12-0.41)
-

<.001
<.001
<.001
<.001
.

<.001

1422

1.01 (1.00-1.02)

0.094

0.094

Covariate

Level

AGE

N

OR Pvalue
<.001
.

Type3 Pvalue
<.001

<.001

Table 13
Multivariable Logistic regression for odds of being a homeless TB case in the state of
Georgia from 2014 to 2018 and sociodemographic and clinical characteristics

Covariate
Sex

Level
M
F

Odds Ratio (95% CI)
4.59 (2.59-8.13)
-

OR Pvalue
<.001
-

Type3 P-value
<.001
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Odds Ratio (95% CI)

OR Pvalue

Asian or AIAN
Black or African
American
White

0.73 (0.31-1.75)
2.22 (1.34-3.68)

0.485
0.002

-

-

Age groups

20-29
30-39
40-49
50+
<20

1.86 (0.61-5.65)
1.44 (0.49-4.24)
2.63 (0.94-7.39)
2.51 (0.96-6.57)
-

0.271
0.511
0.067
0.061
-

0.133

HIV status

Positive
Negative

1.90 (1.13-3.18)
-

0.015
-

0.015

Foreign Born Yes
No

0.35 (0.20-0.62)
-

<.001
-

<.001

Diagnosis
year

0.37 (0.22-0.62)
0.31 (0.18-0.53)
0.21 (0.11-0.39)
0.22 (0.12-0.43)
-

<.001
<.001
<.001
<.001
-

<.001

Covariate
Race

Level

2015
2016
2017
2018
2014
* Number of observations used = 1422.

Type3 P-value
0.001

Population with N=1518 with 1369 not homeless, 145 homeless and 4 unknown
cases for the state of Georgia from 2014 to 2018. According to multivariate logistic
regression analysis for RQ #3, there was no significant association related to age groups
(Table 13) for odds of being a homeless TB case in Georgia. While adjusting for other
variables such as sex, race, HIV, foreign-born and diagnosis year with the p-value <0.005
where there was significance. Missing cases were not included in the analysis. Since
these numbers are less than 0.05 that means according to data there is statistical
significance to predict or impact on the dependent variable homelessness in TB cases
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supporting the alternative hypothesis. There is a relationship between homelessness in TB
cases in terms of origin of birth for the state of Georgia from 2014 to 2018. Null
hypothesis is rejected in this particular case while alternative hypothesis is supported.
The analysis tables 5, 8, and 11 are derived from data calculated from CDC OTIS
website online count calculations system (https://wonder.cdc.gov/TB-v2019.html); while
tables 6, 7, 9, 10, 12, and 13 are derived from logistic regression of data received from
GA Department of Public Health (GA DPH). In absence of complete raw data from GA
DPH, regression analysis was done on limited variables.
Tables 5, 8, and 11 show distribution of socio-demographic and clinical factors
stratified by predefined dependent variables such as origin of birth, HIV status, and
homelessness. All p-values are tested based on Chi-square testing.
Univariable logistic regression performed in tables 6, 9, and 12 show odds ratios
along with 95% confidence intervals and p-values for logistic regression tests for
respective dependent variables and available independent variables from GA DPH data
file.
Multivariable logistic regression 7, 10, and 13 show effect of primary independent
variables in respective tables. OR p-value reflects significance at specific level [e.g.,
Asian vs White, Black vs White, where White is a reference category] while, Type-3 pvalue shows significance at group level [e.g., Race as a factor for predicting dependent
variable].
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1. Table 7: While adjusting for race, age, homelessness, HIV status, and diagnosis year; a
male with TB is 33% less likely to be born outside of the United States as compared to a
female TB patient [0.66 (0.53-0.82), p=<.001] in state of GA during 2014 to 2018.
2. Table 10: While adjusting for gender, age, homelessness, origin of birth, and diagnosis
year; an African American patient with TB is 3.3 times more likely to be HIV positive as
compared to a white patient with TB. Similarly, an Asian patient with TB is 45% less
likely to be HIV positive as compared to a white patient with TB.
3. Table 13: While adjusting for race, age, homelessness, HIV status, original of birth,
and diagnosis year; a male patient with TB is 4.6 times more likely to be homeless than a
female patient with TB.
Additionally, there are three bar charts 1, 2, and 3 below presenting comparison
of the U.S.-born vs foreign-born population in bar chart #1 where we see more U.S.-born
than foreign- born TB cases for the state of Georgia during 2014 to 2018.
Bar chart # 2 is presenting comparison of HIV negative, HIV positive and other cases
labeled as 999. There were more HIV negative than HIV positive TB cases for the state
of Georgia during 2014 to 2018.
Bar chart #3 is presenting comparison of homeless vs not homeless TB cases in the state
of Georgia during 2014 to 2018.

69

Figure 1
Bar Chart 1 U.S.-Born/Foreign-Born
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Figure 2
Bar Chart 2 - HIV
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Figure 3
Bar Chart 3 - Homeless
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Section 4: Application to Professional Practice and Implications for Social Change
Public health efforts should be focused on the homeless population in the United
States, particularly in the state of Georgia, because the research problem was focused on
this state, as well as on HIV and TB regular testing for the most impact to reduce the
level of poverty and the infection rate when it comes to TB and HIV. These types of
interventions, for example affordable housing for homeless and easily accessible clinic
centers for TB/HIV, are the best recommended ways to achieve the reduced number of
homeless and TB/HIV positive patients.
Sociodeterminants of health have indicated that certain populations are at a much
higher risk of chronic, infectious and other diseases compared to some other populations.
In particular, the HIV positive and homeless population are extra prone to contracting
infectious disease such as TB. In the United States, there has been a low prevalence of
TB among the U.S.-born population, but there is a higher prevalence for the U.S. foreignborn population (immigrants). For example, there was a jump of about 4% in 1990 to
about 11% in 2010 (Marks et al., 2019). The challenge with this significant increase is
that TB is an airborne infectious disease that can easily be transferred through the air
from one infected person to another. Over the years, the United States has seen an
increase in immigrant population as well as in the homeless population; thus, it is
imperative to find a solution to the increasing rates of TB in the United States.
My current interest in TB/HIV and homelessness continues because GA is my
home state, and there was a gap and unknown/unavailable records of TB cases and
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differences between the U.S.-born vs. foreign-born population in GA from 2014 to 2018,
taking into consideration sociodemographic and clinical characteristics of the population.
I used three research questions to illustrate the relationship between the dependent
and independent variables. Using the latest SPSS Version 25, statistical quantitative data
analysis was performed, and the data were presented in Section 3 of the manuscript.
Section 4 addresses the discussion of the results of statistical analysis with the relevant
recommendations based on the research done.
Interpretation of the Findings
There were three dependent variables (origin of birth, HIV, homelessness) in TB
cases with three hypotheses. There is a relationship of TB cases based on origin of birth
and differences between the U.S.-born and foreign-born population for the state of GA
from 2014 to 2018. All alternative hypotheses were accepted while the null hypotheses
were rejected due to calculated p values where the origin of birth was defined as the
actual outcome variable in TB cases. According to initial findings using Chi-square
analysis, I determined that U.S.-born TB cases were more likely to have HIV positive
status compared to foreign-born TB cases where there was no significance related to HIV
status for the state of GA from 2014 to 2018. Next, using multivariate logistic regression
analysis findings, I further evaluated the relationships among different variables,
including origin of birth, HIV, homelessness, and clinical characteristics in TB cases.
Comparing these initial findings according to Chi-square analysis, I found that
U.S.-born TB cases were more likely to be homeless compared to foreign-born TB cases
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in the state of GA between 2014 and 2018. The number of TB cases was greater for the
U.S.-born population vs. the foreign-born population from 2014 to 2018 in GA.
On the other hand, multivariate logistic regression analysis revealed that
homelessness was strongly associated with origin of birth in TB cases for GA. For
example, I found that a male with TB was 33% less likely to be born outside United
States as compared to a female TB patient in state of GA between 2014 and 2018 (Table
13). A Black patient with TB was 3.3 times more likely to be HIV positive as compared
to a White patient with TB. Similarly, an Asian patient with TB was 45% less likely to be
HIV positive as compared to a White patient with TB. Furthermore, a male patient with
TB was 4.6 times more likely to be homeless than a female patient with TB.
The results of this research support the SEM theoretical framework on which the
study was based. Homelessness directly affects TB cases in the U.S.-born/foreign-born
population by shaping individual behavior. Thus, organizations, communities, and statelevel officials need to implement specific policies at local and state levels in GA. As
mentioned earlier, in light of my personal and professional engagement and interest in
TB, HIV, and homelessness, a socioenvironmental framework was the best option for this
research. A socioenvironmental framework can be used to continue to develop strategies
in the implementation process that can be helpful in tracking and preventing TB in the
state of GA. In my summary of findings, I further discuss populations of groups most
affected.
The alternative hypotheses were supported and presented below:

75
H1A: There is a relationship between the sociodemographic and clinical
characteristics of U.S. born and foreign-born population (origin of birth) in TB cases for
the state of Georgia from 2014 to 2018.
H2A: There is a relationship between HIV status in TB cases for the state of
Georgia from 2014 to 2018.
H3A: There is a relationship between homelessness in TB cases for the state of
Georgia from 2014 to 2018.
Summary of Findings
Quantitative data analysis indicated a total number of TB cases (N = 1,518) for a
period of time from 2014 to 2018 with 987 males and 531 females included within the
secondary dataset. There were more males infected with TB than females. In terms of
race, the dataset showed 717 Blacks, 417 Whites, and 366 Asians for the same time
period of 2014 to 2018 in the GA where the rates remained stable. My particular focus
was on the foreign-born population in GA from 2014 to 2018 where the top 10 countries
of origin of birth were 122 from Mexico, 115 from India, 78 from Vietnam, 49 from
Ethiopia, 31 from Guatemala, 29 from Burma, 24 from Nigeria, 19 from Honduras, 19
from Korea, and 19 from the Philippines.
For positive HIV cases who were also TB positive, 83 cases were U.S.-born while
49 were foreign-born. The origin of birth for these 49 who were both TB and HIV
positive included 10 from the continent of Africa, three from Central America, and two
from Asia. Homeless status for this particular group was much more closely analyzed.
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For example, out of 145 homeless cases within this secondary dataset, there were 116
HIV negative cases and 29 HIV positive cases. These 29 cases were TB positive, HIV
positive, and homeless at the same time. Homeless status in these 145 cases included 118
U.S.-born and 27 foreign-born patients.
While adjusting for race, age, homelessness, HIV status, and diagnosis year, a
male with TB was 33% less likely to be born outside United States as compared to a
female TB patient in GA from 2014 to 2018, as presented in Table 7. While adjusting for
gender, age, homelessness, origin of birth, and diagnosis year, a Black patient with TB
was 3.3 times more likely to be HIV positive as compared to a White patient with TB.
Similarly, an Asian patient with TB was 45% less likely to be HIV positive as compared
to a White patient with TB, as presented in Table 10. While adjusting for race, age,
homelessness, HIV status, original of birth, and diagnosis year, a male patient with TB
was 4.6 times more likely to be homeless than a female patient with TB.
As a result of this study, I determined that there are more HIV positive and
homeless TB cases in the U.S.-born population in GA, compared to the foreign-born
population. This result may help to reduce social stigma when it comes to immigrants.
Limitations
When it comes to HIV status out of total number of TB cases (N=1518), there
were 48 not offered HIV testing, 25 refused and 19 with unknown HIV status. Total
number of these cases who were not offered HIV testing, refused to test for HIV and for
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whatever not specified reasons were unknown cases whether they had or did not have
HIV could impact our study.
Additional limitation was regarding the overall challenge to keep track of TB
cases in the state of Georgia for immigrant population from 2014-2018 due to political
climate. What this means is that there are many immigrants who may not have legal
status in the United States, either for that reason or other reasons lack healthcare
insurance, or do not ask for any medical assistance even in case they get sick. According
to Tarantola (2019), the reason why immigrants are hesitating to test for TB/HIV or
adhere to any treatments are partially due to social stigma. Many also come from poverty
and do not have any preventive measures when it comes to their health. These TB cases
could well be underreported for foreign-born population.
This study did explore additional characteristics of the study participants or cases
for example sociodemographic and clinical characteristics to make the study more robust
and look into different relationships with all the other variables, but the secondary dataset
CDC WONDER OTIS did not have all the secondary data available to export into Excel
spreadsheet. Multivariate logistic regression analyses were conducted, but for RQ#1 there
were some limitations in terms of secondary data available through the website. The
findings could not be generalized to other populations in other states across the United
States based on the state of Georgia results.
Another major limitations and gaps in research were the ability to perform even
more robust quantitative data analysis using additional statistical methods based on what
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secondary dataset was retrieved at this time. Due to current pandemic, there was a major
delay and lack of communication with the appropriate agencies to get additional
information regarding the dataset. Under normal circumstances, the level of
communication and flow of information and data can be strengthened for any future
studies in this area.
Implications for Social Change
According to Tarantola, (2019), social change is associated with some
development issues in developing countries to where in early 1990s it became not only an
issue in developing countries but a global issue around the world. Latest studies indicate
social change has gone through transformation to where income, productivity and gross
national product (GNP) continue to be part of human development and communication is
the key aspect of any social change (Tarantola, 2019).
Based on my research on social change aspects, healthcare workers and
community leaders can improve communication when it comes to TB, HIV and
homelessness in the state of Georgia regardless of origin of birth. There is social stigma
around the world when it comes to TB, HIV and homeless status and many of patients are
ashamed of the status and challenges they are facing. Society as a whole need to be more
accepting and supportive for their family, friends or strangers who are coping with these
issues.
Lastly, local, state and federal government can provide additional funding and
other resources in fighting these infectious diseases such as social workers who could
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provide emotional support, reassure patients with TB and HIV there is less stigma
associated with these diseases and there is always “helping hand” in their difficult
journey to get better.
Recommendations for Action and Future Studies
This study shows the importance and significance of studying origin of birth in
TB cases and how they can impact HIV status, homeless status for the state of Georgia
from 2014 to 2018. The findings might be of interest for local, state and federal
government where resources could be identified and used in the state of Georgia. There
are also differences between the counties in the state of Georgia, as some counties will
have more and some less of immigrants vs. U.S.-born population map distribution across
the state of Georgia. As mentioned earlier in the limitation section, there should be
further research that explores characteristics of study participants or cases such as
demographic, clinical, and/or social with the information on exposures, potential
confounders and measures of central tendency as well as multivariate analyses to be
performed.
Conclusion
Infectious disease such as TB has been around for centuries, but it keeps
re-occurring and in some cases is becoming so drug resistant that more research would
have to be done even in the United States. As one of the most advanced countries when it
comes to medicine and medical treatments, United States still has many TB cases and it
was surprising to find out more US-born TB cases will also be more likely homeless in
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the state of Georgia from 2014 to 2018 compared to foreign-born TB cases. Additionally,
in these TB cases, U.S.-born populations will more likely be HIV positive compared to
foreign-born population in the state of Georgia looking at the same secondary data from
2014 to 2018. State of Georgia needs to rely and invest more on public health
professionals, local and state agencies to reduce the level of poverty by building
affordable housing for homeless and mini clinics for regular HIV/TB testing in order to
prevent spread of these infectious diseases. These HIV/TB testing centers could be easily
accessible and offer free of charge testing for vulnerable populations. According to
MMWR (2020), TB incidence rates should be reported in automatic centralized system
for tracking purposes to further evaluate contacts of TB patients, same way of HIV or
homeless in TB cases in order to achieve the national goal of TB elimination.
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